Sofwave Receives FDA Clearance for Treating Upper Arm Skin Laxity
The FDA clearance of Sofwave to treat upper arm skin laxity comes as the American Society of Plastic Surgeons reports brachioplasty procedures grew 25% between 2019-2022.
The FDA clearance of Sofwave to treat upper arm skin laxity comes as the American Society of Plastic Surgeons reports brachioplasty procedures grew 25% between 2019-2022.
Integrating retail skincare into plastic surgery practices improves patient outcomes, boosts satisfaction, and supports healing. By offering medical-grade products tailored to each procedure, surgeons can provide comprehensive care while enhancing practice revenue and reputation. Learn how skincare aligns with surgical results to set new standards in patient care and practice growth.